Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.

Schaule, Jana, Kroeze, Stephanie G C, Blanck, Oliver, Stera, Susanne, Kahl, Klaus H, Roeder, Falk, Combs, Stephanie E, Kaul, David, Claes, An, Schymalla, Markus M, Adebahr, Sonja, Eckert, Franziska, Lohaus, Fabian, Abbasi-Senger, Nasrin, Henke, Guido, Szuecs, Marcella, Geier, Michael, Sundahl, Nora, Buergy, Daniel, Dummer, Reinhard and Guckenberger, Matthias (2020) Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score. Radiation oncology (London, England), 15 (1). p. 135. ISSN 1748-717X

Preview

Text (Artikel in PDF)
Schaule et al_Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy_Radiation Oncology_2020.pdf - Published Version
Download (761kB) | Preview

Edit Item